RSCF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
8.35M
RSMDF
Price
$22.00
Change
-$8.00 (-26.67%)
Updated
Apr 29 closing price
Capitalization
32.67B
31 days until earnings call
Interact to see
Advertisement

RSCF vs RSMDF

Header iconRSCF vs RSMDF Comparison
Open Charts RSCF vs RSMDFBanner chart's image
Reflect Scientific
Price$0.06
Change-$0.00 (-0.00%)
Volume$138.75K
Capitalization8.35M
Resmed
Price$22.00
Change-$8.00 (-26.67%)
Volume$363
Capitalization32.67B
RSCF vs RSMDF Comparison Chart in %
Loading...
RSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RSCF vs. RSMDF commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSCF is a Hold and RSMDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (RSCF: $0.05 vs. RSMDF: $21.95)
Brand notoriety: RSCF and RSMDF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: RSCF: 197% vs. RSMDF: 89%
Market capitalization -- RSCF: $8.35M vs. RSMDF: $32.67B
RSCF [@Medical Specialties] is valued at $8.35M. RSMDF’s [@Medical Specialties] market capitalization is $32.67B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RSCF’s FA Score shows that 1 FA rating(s) are green whileRSMDF’s FA Score has 1 green FA rating(s).

  • RSCF’s FA Score: 1 green, 4 red.
  • RSMDF’s FA Score: 1 green, 4 red.
According to our system of comparison, RSMDF is a better buy in the long-term than RSCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RSCF’s TA Score shows that 1 TA indicator(s) are bullish.

  • RSCF’s TA Score: 1 bullish, 3 bearish.

Price Growth

RSCF (@Medical Specialties) experienced а +1.85% price change this week, while RSMDF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.51%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was +2.89%.

Reported Earning Dates

RSMDF is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+2.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RSMDF($32.7B) has a higher market cap than RSCF($8.35M). RSCF has higher P/E ratio than RSMDF: RSCF (50.76) vs RSMDF (37.59). RSCF YTD gains are higher at: 30.952 vs. RSMDF (-3.737). RSMDF has higher annual earnings (EBITDA): 1.31B vs. RSCF (-207.37K). RSMDF has more cash in the bank: 228M vs. RSCF (1.2M). RSCF has less debt than RSMDF: RSCF (42.2K) vs RSMDF (1.72B). RSMDF has higher revenues than RSCF: RSMDF (4.02B) vs RSCF (1.53M).
RSCFRSMDFRSCF / RSMDF
Capitalization8.35M32.7B0%
EBITDA-207.37K1.31B-0%
Gain YTD30.952-3.737-828%
P/E Ratio50.7637.59135%
Revenue1.53M4.02B0%
Total Cash1.2M228M1%
Total Debt42.2K1.72B0%
FUNDAMENTALS RATINGS
RSCF vs RSMDF: Fundamental Ratings
RSCF
RSMDF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
17
Undervalued
PROFIT vs RISK RATING
1..100
9974
SMR RATING
1..100
9038
PRICE GROWTH RATING
1..100
4861
P/E GROWTH RATING
1..100
266
SEASONALITY SCORE
1..100
16n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSMDF's Valuation (17) in the null industry is somewhat better than the same rating for RSCF (73). This means that RSMDF’s stock grew somewhat faster than RSCF’s over the last 12 months.

RSMDF's Profit vs Risk Rating (74) in the null industry is in the same range as RSCF (99). This means that RSMDF’s stock grew similarly to RSCF’s over the last 12 months.

RSMDF's SMR Rating (38) in the null industry is somewhat better than the same rating for RSCF (90). This means that RSMDF’s stock grew somewhat faster than RSCF’s over the last 12 months.

RSCF's Price Growth Rating (48) in the null industry is in the same range as RSMDF (61). This means that RSCF’s stock grew similarly to RSMDF’s over the last 12 months.

RSCF's P/E Growth Rating (2) in the null industry is somewhat better than the same rating for RSMDF (66). This means that RSCF’s stock grew somewhat faster than RSMDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSCFRSMDF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
32%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
28%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
RSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMMYY6.160.30
+5.12%
Sumitomo Metal Mining Co., Ltd.
TBNGY3.49N/A
N/A
PT Bukit Asam Persero TBK
BMKDF0.23N/A
N/A
Biomark Diagnostics Inc.
DENI15.80N/A
N/A
Denali Bancorp Inc
GLNLF0.06N/A
N/A
GALAN LITHIUM LTD.

RSCF and

Correlation & Price change

A.I.dvisor tells us that RSCF and MXCT have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSCF and MXCT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSCF
1D Price
Change %
RSCF100%
N/A
MXCT - RSCF
22%
Poorly correlated
-4.35%
BRSYF - RSCF
20%
Poorly correlated
N/A
RSMDF - RSCF
10%
Poorly correlated
N/A
RYLPF - RSCF
6%
Poorly correlated
+2.78%
PFGTF - RSCF
3%
Poorly correlated
N/A
More

RSMDF and

Correlation & Price change

A.I.dvisor tells us that RSMDF and NAOV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSMDF and NAOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSMDF
1D Price
Change %
RSMDF100%
N/A
NAOV - RSMDF
30%
Poorly correlated
+34.62%
PODD - RSMDF
25%
Poorly correlated
+1.05%
ANIK - RSMDF
25%
Poorly correlated
-0.83%
FLGT - RSMDF
25%
Poorly correlated
+0.41%
PACB - RSMDF
24%
Poorly correlated
N/A
More